<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03249610</url>
  </required_header>
  <id_info>
    <org_study_id>Worksite_2014</org_study_id>
    <nct_id>NCT03249610</nct_id>
  </id_info>
  <brief_title>Randomized Control Trial for Overweight Employees in Worksites</brief_title>
  <official_title>Worksite Intervention Trial With Multi-Component Lifestyle Intervention and Digital Health Platform for Reduction of Body Weight and Cardio-metabolic Risk Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diabetes Foundation, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sprim Global Investments Pte Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abbott India Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Diabetes Foundation, India</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Impact of lifestyle intervention in at-risk Asian Indians at worksite remains largely
      unexplored. The aim of this study was to assess impact of the multi-component interventions
      on body weight, body fat patterning and cardio-metabolic risk factors in overweight
      individuals working in corporate worksites in New Delhi, north India.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized open label clinical trial is planned in 4 worksites. The total study duration is
      18 months. Four workplace sites will be divided into two active intervention and two control
      sites. Intensive awareness generation activities for overweight and obese employees and a
      general awareness health, nutrition and physical education programme for the rest of the
      employees. The study subjects will be part of awareness sessions which will be conducted in
      the 6 month intervention period. Besides group sessions individual diet charts will also be
      worked out by a trained nutritionist. Physical activity advice will be provided to them
      keeping their specific requirements in mind. Pedometers will be provided to them and they
      will be encouraged to walk for 15 minutes in pre-lunch period. Leg movements at the desk will
      also be encouraged.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 11, 2014</start_date>
  <completion_date type="Actual">June 15, 2017</completion_date>
  <primary_completion_date type="Actual">March 12, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with reduced Body Mass Index</measure>
    <time_frame>6 months</time_frame>
    <description>Body Mass Index measured in kg/m^2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with reduced Fasting Blood Glucose</measure>
    <time_frame>6 months</time_frame>
    <description>Fasting Blood Glucose measured in mg/dl</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Lifestyle Risk Reduction</condition>
  <arm_group>
    <arm_group_label>Jindal Steel Pvt Ltd</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lifestyle intervention given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maruti Udyog Ltd</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lifestyle intervention given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tata Capital</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control arm so no intervention given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Powergrid Corporation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control arm so no intervention given</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle intervention</intervention_name>
    <description>Intervention Trial with Multi-Component Lifestyle Intervention for reduction of body weight and cardio-metabolic risk factors</description>
    <arm_group_label>Jindal Steel Pvt Ltd</arm_group_label>
    <arm_group_label>Maruti Udyog Ltd</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight (â‰¥23kg/m 2 ) individuals in the age group 25-55 years

          -  Individuals who are willing to participate in the study

        Exclusion Criteria:

          -  Previously diagnosed diabetics and patients with coronary artery disease.

          -  Have received any medication within last one month which could potentially influence
             insulin secretion, insulin sensitivity, (e.g. metformin, thiazolidinediones, steroids
             etc.) and on any medication that activate steroid and xenobiotic receptors

          -  Pregnant and lactating women

          -  Severe end organ damage or chronic diseases:renal/hepatic failure, any malignancy,
             major systemic illness etc.

          -  Known case of HIV infection

          -  Unwillingness to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Anoop Misra</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diabetes Foundation, India</affiliation>
  </overall_official>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2017</study_first_submitted>
  <study_first_submitted_qc>August 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2017</study_first_posted>
  <last_update_submitted>August 12, 2017</last_update_submitted>
  <last_update_submitted_qc>August 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diabetes Foundation, India</investigator_affiliation>
    <investigator_full_name>Dr Anoop Misra</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

